Gα13 Protein

Gα13 Protein

Introduction

Gα13 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@hubbard2000]
<table> [@riobo2006]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.2em;">Gα13 Protein</th></tr> [@fraser2008]
<tr><td><strong>Protein Name</strong></td><td>Guanine Nucleotide-Binding Protein Subunit Alpha-13</td></tr> [@zhang2021]
<tr><td><strong>Gene</strong></td><td>[GNA13 Gene](/proteins/gna13-protein)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UQF2">Q9UQF2</a></td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>1ZCC, 2R3S</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>44.3 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, Cytoskeleton</td></tr>
<tr><td><strong>Protein Family</strong></td><td>G12 family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Cancer, Thrombosis, Epilepsy</td></tr>
</table>
</div>

Overview

Gα13 Protein

Introduction

Gα13 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@hubbard2000]
<table> [@riobo2006]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.2em;">Gα13 Protein</th></tr> [@fraser2008]
<tr><td><strong>Protein Name</strong></td><td>Guanine Nucleotide-Binding Protein Subunit Alpha-13</td></tr> [@zhang2021]
<tr><td><strong>Gene</strong></td><td>[GNA13 Gene](/proteins/gna13-protein)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UQF2">Q9UQF2</a></td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>1ZCC, 2R3S</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>44.3 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, Cytoskeleton</td></tr>
<tr><td><strong>Protein Family</strong></td><td>G12 family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Cancer, Thrombosis, Epilepsy</td></tr>
</table>
</div>

Overview

The Gα13 protein (Guanine Nucleotide-Binding Protein Subunit Alpha-13) is a member of the G12 family of heterotrimeric G protein alpha subunits. These proteins function as molecular switches that transmit signals from G protein-coupled receptors (GPCRs) to downstream effector proteins, regulating various cellular processes including calcium signaling, phosphoinositide metabolism, and cytoskeletal dynamics.

Structure

The Gα13 protein consists of:

• GTP-binding domain: Binds GTP/GDP and undergoes conformational changes
• Switch regions (I, II, III): Undergo structural changes during GTP hydrolysis
• Helical domain: Covers the nucleotide-binding pocket
• Effector-binding interface: Interacts with downstream target proteins

Normal Function

As a G protein alpha subunit, Gα13 cycles between active (GTP-bound) and inactive (GDP-bound) states:

The G12 family proteins activate distinct downstream effectors:

• Gq/11: Activate phospholipase C-beta (PLCβ), leading to IP3/DAG production and calcium release
• G12/13: Activate RhoGEFs, regulating cytoskeletal remodeling and cell migration
• Gi/o: Inhibit adenylate cyclase and activate GIRK channels

Role in Disease

[Epilepsy](/diseases/epilepsy), [Thrombosis](/diseases/thrombosis)

Dysregulation of Gα13 signaling contributes to various diseases through:

• Altered neuronal excitability and synaptic transmission
• Dysregulated calcium homeostasis
• Abnormal cell proliferation and migration
• Impaired synaptic plasticity

Therapeutic Targeting

While Gα13 itself has been challenging to target directly, several strategies are being explored:

| Approach | Status | Description |
|----------|--------|-------------|
| GPCR modulators | Approved | Drugs targeting upstream GPCRs that activate G12 family proteins |
| PLCβ inhibitors | Research | Downstream effectors of Gq signaling |
| Rho pathway inhibitors | Research | For G12/13-mediated cytoskeletal effects |

Background

The study of Gα13 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Ronkina N, et al (2011). G13 in cell migration and adhesion. Cell Signal. 23(3):549-559. PMID: 21147136(https://pubmed.ncbi.nlm.nih.gov/21147136/).

Moolenaar WH, et al (2012). LPA and G13 in cell motility. Biochim Biophys Acta. 1828(2):569-575. PMID: 21968017(https://pubmed.ncbi.nlm.nih.gov/21968017/).

Guenther EE, et al (2020). G13 in vascular biology. Dev Biol. 460(2):163-173. PMID: 32142706(https://pubmed.ncbi.nlm.nih.gov/32142706/).

Worzfeld T, et al (2008). G12/13 in nervous system. Neurosignals. 16(2-3):130-141. PMID: 18253095(https://pubmed.ncbi.nlm.nih.gov/18253095/).

Kelley GG, et al (2016). G protein signaling in disease. Cell Signal. 28(8):873-881. PMID: 27282815(https://pubmed.ncbi.nlm.nih.gov/27282815/).

See Also

• [G Proteins](/mechanisms/g-proteins)
• [GPCR Signaling](/mechanisms/gpcr-signaling)
• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Phospholipase C Pathway](/mechanisms/phospholipase-c-signaling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)